Annual Congress on
Rehabilitation and Future Pharma

Human Performance, Human Movement Anatomy, Ph.D. in Neuroscience, Research Psychology, Traumatology& Orthopedics, Project Manager, Strength and Conditioning specialist Physical Therapy, Skynesiology and Spinology, Exercise Physiology, Spa Therapist Physiology Support Health Worker, aesthetic medical, sports masseur, an expert in postural gymnastics, psychology, and psychomotor for the elderly and special children or with learning disabilities. Coach and athletic trainer of various sports (football, swimming, volleyball, basketball, hockey, tennis, swimming). Spa &Clinical Manager, Lecture in neuro rehabilitation kinesiology, specialist in aesthetic gymnastics, weight-loss and pre and post-natal, Osteopathy, Psicomotricist, aesthetic and lymphatic drainage. The lines of research on which I worked at the Department of Biotechnology and Biomedical Sciences, section of applied physiology and kinesiology and motion control, have been in the field of neuroscience, in particular in the role of beta-amyloid and glycoprotein F3 in the synaptic plasticity of hippocampal memory of mice and then in Alzheimer's disease; I dealt with behavior and various behavioural tests in mice; of electrophysiology of in vitro slices of hippocampus, stereotaxy and cannulation implantation, administration of drugs and animal welfare. In addition, I have helped other laboratories in the analysis of human movement, in neuropharmacology, in motor learning and control, in the performance of elite athletes in training programming, in rehabilitation, in the measurement of lactate in the physiology of physical exercise.

Human Movement Anatomy, Neuroscience, Research Psychology,Traumatology & Orthopedic

Dr. Karena Wu is the Owner and Clinical Director of ActiveCare Physical Therapy® in NYC and Mumbai. She is a native of Los Angeles, California, and has a Bachelor of Science in Biology from the University of California at Riverside. She has been practicing physical therapy for over 19 years in New York City. She graduated with a Masters Degree in Physical Therapy from the Program In Physical Therapy at Columbia University and received her Clinical Doctorate in Physical Therapy from Temple University. She has advanced training in manual therapies, specifically in the Maitland Australian Approach and Myofascial Release. She is a Board-Certified Clinical Specialist in Orthopedic Physical Therapy. Karena is also a Certified Orthopedic Manual Therapist, Strength and Conditioning Specialist, Kinesiology Tape Practitioner, and Pilates Instructor. She holds LSVT BIG, FMS, and SFMA Level 1 certifications as well.

Physical Therapy

Dr. Ian James Martins is an Editor/Reviewer for Open Acess Pub/MDPI journals/other international journals. He is Advisory Board Member for Photon Journal. He is a Fellow of the International Agency for Standards and Ratings (IASR). He conferred with the RICHARD KUHN RESEARCH AWARD-2015 ENDOCRINOLOGY AND METABOLISM. He is Chief Editor for International Journal of Diabetes Research (2014-2019), Research and Reviews: Neuroscience (2016-2019) and Journal of Diabetes and Clinical Studies (2017-2019). He is BIT Member (BIT Congress. Inc) with an H-index of 65 and Scientist for The Science Advisory Board (USA) and an Academic with Academia.edu with citations >4800. Researchgate Analysis: RG score (>96%) of international Scientists. He acquired 71 International Certificates. He is a reviewer for approx. 47 journals over the past five years. Now he is in the 98th percentile as assessed for Publons users by merit. He is Advisory Committee and Organizing Board Member for various international conferences (2018-2019).

Anti-Aging, Global Health, and Chronic Disease. Keywords: Anti-Aging Genes, Appetite, Environment, Nutrition, Senescence IMPACT OF PREVIOUS RESEARCH TO THE FIELD OF MEDICINE AND LABORATORY TECHNOLOGY THAT MAY AVOID INADVERTENT ERRORS AND MAY TRANSLATE TO COMMERCIALISATION OF MEDICAL RESEARCH THAT determines CRITICAL HEALTH OUTCOMES. Development of a BLOOD TEST has been of critical interest to the for metabolic disease with relevance to diabetes and neurodegenerative diseases. Interests in Biomarker Research have escalated with relevance to mitochondrial survival and organ disease in diabetes and Alzheimer's disease.

Dr Grob is passionate about utilizing technology to empower people to live better and do their jobs better. He has trained in occupational preventative medicine and has functioned as a clinical investigator in multiple pharmaceutical trials. His broad background in medicine, AI predictive analytics, and drug development augment his interest in pharmacovigilance. He obtained a BS in biochemistry from SUNY Stony Brook, and graduate work in public health and economics at SUNY Albany and Harvard before completing his MPH at the University of Minnesota School of Public Health. His expertise in VR and AR is self guided and fueled by coffee

General Surgery

Russell Elliott, Ph.D., has served as the Vice President of Drug Development since May 2016. Dr. Elliott has over 25 years of industry experience, previously holding positions as Head of Skincare Technology at Lonza Inc. from 2015 to 2016, Head of Product Development at Stiefel (a GSK Company) from 2011 to 2014, Head of the Center of Excellence for Liquids, Cream and Ointments at GSK (UK) from 2007 to 2011, and Principal Scientist at Procter & Gamble from 1992 to 2007. He has filed more than 60 patent applications in the area of skincare formulation. Dr. Elliott has a PhD and MA from The University of Oxford and is a Fellow of the Royal Society of Chemistry

Drug development

Dr. Elder has nearly 40 years of service within the pharmaceutical industry (Sterling, Syntex, and for the last two decades with GSK). He is now an independent CMC consultant and has broad-based experience in excipients, biopharmaceutics, drug products, and analytical method development. Dr. Elder obtained his Ph.D. in crystallography from the University of Edinburgh. Dr. Elder is a visiting professor at King’s College, London. He is a member of the British Pharmacopoeia. He is the immediate past chairman of JPAG (Joint Pharmaceutical Analysis Group). He is a member of the Editorial Advisory Board for the Journal of Pharmaceutical Sciences. He has published 114 and presented 17 webinars and 133 presentations. He has co-edited one book on the Analytical Characterization and Separation of Oligonucleotides and their Impurities (with George Okafor and Mike Webb) and is editing a second book on the ICH Quality Guidelines (with Andy Teasdale, AZ).

Dr. Elder has a long-standing interest in impurities and degradation chemistry. He has played a leading role in the identification, analysis and control of mutagenic impurities. He has been part of EfPIA and PhRMA sub-groups on mutagenic impurities and the PQRA group that investigated the formation and control strategies for alkyl sulfonate impurities. He is interested in the role that excipients play in stabilizing/destabilizing molecules and the impact that changes in excipient material attributes can have on processability of drug products. He is interested in biopharmaceutics and its role in devising formulation strategies, as well as the more classical role that biopharmaceutics plays in biowaivers, bioavailability and bioequivalence studies. He is interested in clinically relevant specifications and whether dissolution tests (and related specifications) can ever really be robust enough to be used in a QC environment and sensitive enough to be truly predictive of clinical outcomes.

Dr. Cavazos, or as his patients address him, has been practicing medicine for over 30 years. He graduated with honors from the University of Michigan Medical School and completed a family medicine residency outside Pittsburgh, PA. After residency he practiced Emergency Medicine in Ohio for nearly 10 years. Despite the hustle and bustle of the ER pace, his patients were always treated with respect and compassion. Dr then moved to New Jersey & worked in various urgent care settings. But he was frustrated with the state of patient care as it only focused on symptom control; not the core issue. He then began studying vitamins, hormones, integrative and regenerative medicine. Dr opened his own practice, DrC360, nearly four years ago and is only looking forward to growth and excitement!

Harnessing the Power of Peptides in Treating Osteoporosis and its sequelae.

Andrew Hague's interest in the technology that was to become CellSonic began in 1987 with the first lithotripter in Britain. Using his own capital, he developed the CellSonic VIPP machines and sold them around the world.

Cancer - diagnosis and treatment, Diabetes - reversal, Alzheimer's disease, Parkinson's disease.

Dr. Aymen Mohmed Elbutran is a surgeon at Kom Hamada general Hospital and procured M. B. B. CH at Al-Azhar University and MSc in Orthopaedic Surgery and Limb Reconstruction surgery at Benha University. He is a Member of the AO Foundation and a member of The Egyptian Society for orthopaedic and trauma surgery.

Orthopedic, Limb Reconstruction surgery, and trauma surgery

Wagih El Masri WEM trained in the specialty of spinal injuries at Stoke Mandeville, Oxford, Guys Hospitals & the USA between 1971 and 1983. To date, he personally treated 10,000 patients with traumatic Spinal Injuries acute, subacute, rehabilitation phases as well as in the long term. He is the author of the concept of “Physiological Instability of the Injured Spinal Cord ”and an advocate for the evidence-based Active Physiological Conservative Management of the patient. He lectured worldwide in developed and developing countries, contributed to the literature with over 140 publications including the Prognostic Indicators of Neurological Recovery, the long-term incidence of Post Traumatic Syringomyelia, and the increased incidence of Bladder Cancer in SCI patients. He held the offices of President of the International Spinal Cord Society & Chairman of the British Association of Spinal Cord Injury Specialists.

Neuroscience